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Mitogen-activated protein kinases (MAPKs) are serine-threonine protein kinases that play the major role in signal transduction
from the cell surface to the nucleus. MAPKs, which consist of growth factor-regulated extracellular signal-related kinases (ERKs),
and the stress-activated MAPKs, c-jun NH2-terminal kinases (JNKs) and p38 MAPKs, are part of a three-kinase signaling
module composed of the MAPK, an MAPK kinase (MAP2K) and an MAPK kinase (MAP3K). MAP3Ks phosphorylate MAP2Ks,
which in turn activate MAPKs. MAPK phosphatases (MKPs), which recognize the TXY amino acid motif present in MAPKs,
dephosphorylate and deactivate MAPKs. MAPK pathways are known to be inﬂuenced not only by receptor ligand interactions,
but also by diﬀerent stressors placed on the cell. One type of stress that induces potential activation of MAPK pathways is the
oxidative stress caused by reactive oxygen species (ROS). Generally, increased ROS production in a cell leads to the activation of
ERKs, JNKs, or p38 MAPKs, but the mechanisms by which ROS can activate these kinases are unclear. Oxidative modiﬁcations of
MAPK signaling proteins and inactivation and/or degradation of MKPs may provide the plausible mechanisms for activation of
MAPK pathways by ROS, which will be reviewed in this paper.
1.Introduction
Mitogen-activated protein kinases (MAPKs) compose a
family of protein kinases that play an essential role in
relaying extracellular signals from the cell membrane to the
nucleus via a cascade of phosphorylation events and are
negatively regulated by MAPK phosphatases (MKPs) [1].
Diverse cellular functions, ranging from cell survival to cell
death, are regulated by MAPK signaling [2]. A number
of extracellular and intracellular stimuli have been shown
to activate MAPK pathways at cellular levels [3], implying
that there may be tight and speciﬁc regulation of MAPK
activationbyacertainstimulus.Interestingly,reactiveoxygen
species (ROS) can activate MAPK pathways [4], but the
mechanism(s) for this eﬀect is unclear.
Besides MAPKs, other signaling molecules (e.g., pro-
tein tyrosine phosphatases, protein tyrosine kinases, and
transcriptional factors) can also be activated by ROS [5],
suggesting that ROS may have meaningful roles as regulators
of cell function or as signaling molecules. Indeed, mounting
evidence supports a physiological role for ROS as a “second
messenger” in intracellular signaling cascades that control
cell growth, proliferation, migration, and apoptosis [5].
Because the MAPK pathways mediate both mitogen- and
stress-activated signals, there has been signiﬁcant interest
in the regulation of these pathways by ROS. This paper will2 Journal of Signal Transduction
focus on the putative mechanisms by which ROS can activate
MAPK pathways in a cell.
2. ROS
ROS include superoxide anion radical (·O2
−), hydroxyl
radicals (·OH), and hydrogen peroxide (H2O2). H2O2 is
not a free radical and a weaker oxidizing agent than the
free radical ·O2
−. However, in the presence of transition
metals such as iron or copper, H2O2 can be oxidized
into the extremely reactive and toxic ·OH via well-known
Fenton reaction. In the cellular systems, ROS are normally
counteractedbyubiquitouslyexpressedantioxidantproteins,
such as superoxide dismutase (SOD), catalase, glutathione
(GSH) peroxidase, thioredoxin, glutaredoxin, and GSH. For
example, SOD can convert ·O2
− into H2O2, whereas catalase
and GSH peroxidase can reduce H2O2.
ROS are constantly produced by a number of normal
cellularevents,withamajorsourcebeingaerobicrespiration,
but ROS produced during these events are generally counter-
acted by several antioxidant proteins [6, 7]. A large amount
of ROS can also be produced by inﬂammatory processes,
ionizing radiation, and many chemotherapeutic drugs, and
this, if the production of ROS exceeds the capacity of the
antioxidant proteins, may cause the so-called “oxidative
stress”; in a biological sense, the oxidative stress may be
broadlydeﬁnedasanimbalancebetweenoxidantproduction
and the antioxidant capacity of the cell to prevent oxidative
injury [5, 7].
Oxidative stress is known to be implicated in many
human diseases, including atherosclerosis, cancer, neurode-
generative diseases, and aging [7]. However, there is still
a debate whether oxidative stress is a cause or a result of
these diseases, largely due to a lack of our understanding
of the mechanisms by which ROS function in both normal
physiological and disease states.
ROS are not only injurious to cell survival but also
essential to cell signaling and regulation, and this may be
dependentonthelevelsofproducedROS.Athighlevels,ROS
can lead to impaired physiological function through cellular
damage of DNA, proteins, phospholipids, and other macro-
molecules, which can lead to certain human pathologies [8].
At low levels, ROS can alter intracellular redox state, leading
to activation of redox-sensitive proteins, and also modify
redox-sensitive parts of proteins, potentially inhibiting or
increasing their enzymatic activity [9, 10]. H2O2,w i t ha
relatively long half-life, good membrane permeability, and
higher intracellular concentration, has been proposed to
function as a second messenger [9, 10]. In this regard, it is
most likely that H2O2 may mimic many actions of ROS in a
cellular system.
3. MAPKs
The MAPKs comprise a family of ubiquitous proline-
directed, protein-serine/threonine kinases, which play an
essential role in sequential transduction of biological signals
from the cell membrane to the nucleus [11]. In mammalian
cells, there are three well-deﬁned subgroups of MAPKs:
MAP3K Raf
MAP2K MEK MKK3/MKK6 MKK4/MKK7
MAPK ERK p38 MAPK JNK
Proliferation, diﬀerentiation,
migration, inﬂammatory responses,
apoptosis, and so forth
ASK1, MEKK1, MEKK3,
and so forth
Growth factors, cytokines, oxidative stress,
and so forth
Figure 1: MAPK cascades. MAPK signaling pathways mediate
intracellularsignalinginitiatedbyextracellularorintracellularstim-
uli. MAP3Ks phosphorylate MAP2Ks, which in turn phosphorylate
MAPKs. Activated MAPKs phosphorylate various substrate pro-
teins (e.g., transcription factors), resulting in regulation of various
cellular activities (e.g., proliferation, diﬀerentiation, inﬂammatory
responses, and apoptosis). Activation by MAPK signaling cascades
is achieved either through a series of binary interactions among
the kinase components or through formation of a multiple kinase
complex.
the extracellular signal regulated kinases (ERKs, including
ERK-1 and ERK-2 isoforms), the c-Jun N-terminal kinases
(JNKs, including JNK-1, JNK-2, and JNK-3 isoforms), and
the p38 MAPKs (including p38-α, p38-β, p38-γ, and p38-δ
isoforms). Each subgroup of MAPKs is activated through
a cascade of sequential phosphorylation events, beginning
with the activation of MAPK kinase kinases (MAP3Ks). The
MAP3Ks phosphorylate and activate a downstream dual-
speciﬁcityMAPKkinases(MAP2Ks),whichinturnstimulate
MAPK activity through dual phosphorylation on threonine
and tyrosine residues within a conserved tripeptide motif
[1, 11]. The well-deﬁned regulation of MAPK signaling
pathways is summarized in Figure 1. It should be noted
that the three subgroups of MAPKs (i.e., ERKs, JNKs,
and p38 MAPKs) are involved in both cell growth and
cell death, and the tight regulation of these pathways is
paramount in determining cell fate [12]. The deleterious
consequences of sustained activation of MAPK pathways
may include excessive production of MAPK-regulated genes,
uncontrolled proliferation, and unscheduled cell death.
3.1. ERKs. ERK pathway is activated by MAP/ERK Kinase
(MEK), which is activated by Raf. Raf, an MAP3K, is
activated by the Ras-GTPase, whose activation is induced
by receptor tyrosine kinases (RTKs) such as the epidermal
growth factor (EGF) receptor [13]. Growth factor receptors
are most commonly activated by ligand-induced dimer-
ization or oligomerization that phosphorylates RTKs [14].
Ligand-independent clustering and activation of growth
factor receptors in response to ROS have also been well
demonstrated [15]. Meves et al. [16] demonstrated thatJournal of Signal Transduction 3
oxidative stress induces EGF receptor activation through
RTK phosphorylation and proposed that H2O2 is a critical
mediator required for ligand-independent phosphoryla-
tion of growth factor receptors in response to oxidative
stress.
3.2. p38 MAPKs. T h ep 3 8M A P K sa r eu s u a l l ya c t i v a t e di n
response to inﬂammatory cytokines, as well as by many
other stimuli, including hormones, ligands for G protein-
coupled receptors, and stresses such as heat shock and
osmotic shock [17]. Two MEK family members, MEK3
(or MKK3) and MEK6 (or MKK6), are highly speciﬁc for
p38 MAPKs [17]. MKK6 can phosphorylate the four p38
MAPK family members, while MKK3 phosphorylates p38α,
p38γ, and p38δ,b u tn o tp 3 8 β. Both will also phosphorylate
JNK isoforms [17]. Several MAP3Ks have been shown
to trigger p38 MAPK activation, and they include ASK1
(apoptosis signal-regulating kinase 1), DLK1 (dual-leucine-
zipper-bearing kinase 1), TAK1 (transforming growth factor
β-activated kinase 1), TAO (thousand-and-one amino acid)
1 and 2, TPL2 (tumor progression loci 2), MLK3 (mixed-
lineage kinase 3), MEKK3 (MEK kinase 3) and MEKK4, and
ZAK1 (leucine zipper and sterile-α motif kinase 1) [17]. The
diversity of MAP3Ks and their regulatory mechanisms may
provide the ability to respond to a wide range of stimuli
and to integrate p38 MAPK activation with other signaling
pathways. It should be noted that some MAP3Ks that trigger
p38 MAPK activation can also activate the JNK pathway.
3.3. JNKs. The JNK pathway is known to be activated by
cytokines, ligation of a variety of receptors, agents that
interfere with DNA and protein synthesis, many other
stresses, and to some extent by serum, growth factors, and
transforming agents [18]. Two MEK family members, MEK4
(or MKK4) and MEK7 (or MKK7), have been implicated
in phosphorylation of JNKs [18]. A number of diﬀerent
MAP3Ks can activate MKK4 and MKK7, suggesting that a
wide range of stimuli can activate this MAPK pathway. These
include MEKK1, 2, 3, and 4, MLK, and ASK1. In addition
to its activation of MKK4 and MKK7, MEKK4 can also
activate MKK3 or MKK6 to activate p38 MAPK pathway,
which depends on the receptor activated and availability of
other signaling molecules [18]. Research into the molecular
mechanisms of oxidative stress-mediated activation of JNK
and p38 pathways has focused on redox-sensitive proteins
such as thioredoxin and glutaredoxin [19]. It is well known
that ROS oxidizes thioredoxin to dissociate from ASK-1 for
its activation, resulting in the activation of JNK and p38
pathways [20].
4. MAPK Phosphates
As above mentioned, MAPK pathways are activated through
phosphorylation.Thus,thedephosphorylationofMAPKsby
phosphatasesislikelythemosteﬃcientmodeofnegativereg-
ulation. A number of protein phosphatases that are known
to deactivate MAPKs include tyrosine, serine/threonine, and
dual speciﬁcity phosphatases [21, 22]. A group of dual speci-
ﬁcity protein phosphatases that are responsible primarily for
dephosphorylation/deactivation of MAP kinases are often
referred to as MAPK phosphatases (MKPs) [21, 22]. Since
MKPs dephosphorylate MAPKs on their regulatory residues,
aberrant regulation of MAPK activity may arise through
defective regulation of the MKPs. The factors that activate
MAPK pathways, such as environmental stresses and growth
factor stimulation, can also activate MKP pathways [21, 22],
supporting the notion that there is tight and speciﬁc control
of MAPK activation and function by MKP activation. In
mammaliancells,atleast11 MKPfamilymembers have been
identiﬁed so far: MKP-1, MKP-2, MKP-3, MKP-4, MKP-
5, MKP-7, MKP-X, PAC1, hVH3, hVH5, and MK-STYX.
According to their subcellular localization, MKPs can be
grouped: (1) MKP-1, MKP-2, hVH3, and PAC1 are found
in the nucleus; (2) MKP-3, MKP-4, and MKP-X are found
in the cytoplasm; (3) MKP-5, MKP-7, and hVH5 are found
in both the nucleus and the cytoplasm [21, 22]. These
MKPs exhibit distinct biochemical properties with regard to
their substrate speciﬁcity [21, 22]. MKP-1 and MKP-2 show
selectivity for p38s and JNKs over ERKs. MKP-3, MKP-X,
and hVH3 primarily inactivate ERKs. MKP-5, MKP-7, and
hVH5 show selectivity for JNKs and p38s, while MKP-4 and
PAC1 inactivate ERKs and p38s.
MKP-1, the archetype, was initially discovered as a
stress-responsive protein phosphatase [23]. Since MKP-1
deactivates MAPKs and is robustly induced by stress stimuli
thatalsoactivateMAPKs,MKP-1isregardedasanimportant
feedback control mechanism that regulates the MAPKs.
Compared with other MKPs, MKP-1 has been most closely
examined. The activity of MKP-1 may be regulated at
multiple levels, including transcriptional induction, protein
stabilization, catalytic activation, and acetylation [24]. It
has been reported that JNK and p38 pathways are highly
activated in MKP-1-deﬁcient mouse embryonic ﬁbroblasts
[25], supporting that MKP-1 functions as a critical negative
regulator during MAPK activation. However, it should be
noted that all MPKs may act cooperatively to modulate
the MAPK pathways and to orchestrate appropriate cellular
responses.
5. Activationof MAPK Pathwaysby ROS
Studies have demonstrated that ROS can induce or mediate
the activation of the MAPK pathways [26]. A number of
cellular stimuli that induce ROS production also in parallel
can activate MAPK pathways in multiple cell types [4, 26].
The prevention of ROS accumulation by antioxidants blocks
MAPK activation after cell stimulation with cellular stimuli
[4, 26], indicating the involvement of ROS in activation
of MAPK pathways. Moreover, direct exposure of cells
to exogenous H2O2, to mimic oxidative stress, leads to
activation of MAPK pathways [27, 28]. The mechanism(s)
by which ROS can activate the MAPK pathways, however,
is not well deﬁned. Because ROS can alter protein structure
and function by modifying critical amino acid residues
of proteins [5], the oxidative modiﬁcation of signaling
proteins by ROS may be one of the plausible mechanisms
for the activation of MAPK pathways. However, the precise
molecular target(s) of ROS is unknown.4 Journal of Signal Transduction
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Figure 2: Putative mechanisms for ROS-mediated activation of
MAPK pathways. ROS are activated by growth factors, cytokines,
and various stresses and rapidly removed by intracellular antiox-
idant proteins. ROS, once ROS production exceeds the capacity
of the antioxidant proteins, may induce oxidative modiﬁcation
of MAPK signaling proteins (e.g., RTKs and MAP3Ks), thereby
leading to MAPK activation. ROS may activate MAPK pathways via
inhibition and/or degradation of MKPs.
Many growth factor and cytokine receptors have
cysteine-rich motifs, the oxidation of which may activate
MAPK pathways, and they, if not all, may be targets of
oxidativestress.Mengetal.[29]determinedthecontribution
of EGF receptor to activation of ERK pathway by insulin-
like growth factor-I (IGF-I) in vascular smooth muscle
cells. They showed that IGF-I induced phosphorylation
of EGF receptor and ERK. AG1478, an EGF receptor
inhibitor, inhibited IGF-I-induced phosphorylation of EGF
receptorandERK,suggestingthatactivationofERKpathway
results from EGF receptor activation. IGF-I stimulated ROS
production and antioxidants inhibited IGF-I-induced ROS
generation and activation of EGF receptor and ERK pathway,
indicating that IGF-I activates ERK pathway through ROS-
mediatedactivationofEGFreceptor.Moreover,Guytonetal.
[30] investigated the factors controlling MAPK activation by
the oxidant H2O2. They found that H2O2 activates MAPK
pathways via activation of growth factor receptors in several
cell types.
ROS may also activate MAPK pathways through
the oxidative modiﬁcation of intracellular kinases (e.g.,
MAP3Ks) that are involved in MAPK signaling cascade.
A S K - 1 ,am e m b e ro ft h eM A P 3 Ks u p e r f a m i l yf o rJ N K
and p38, binds to reduced thioredoxin in nonstressed cells.
Upon an oxidative stress, thioredoxin becomes oxidized and
disassociates from ASK-1, leading to activation of JNK and
p38 pathways through oligomerization of ASK-1 [31]. A
study has been shown that ASK-1-knockout mice exhibited
lower levels of JNK and p38 activation in comparison to wild
type after oxidant treatment [32]. Besides ASK-1, there may
be other redox-sensitive MAP3Ks or MAP2Ks that can also
activate MAPK pathways.
Another potential mechanism for MAPK activation
by ROS may include the inactivation and degradation
of the MKPs that maintain the pathway in an inactive
state. Kamata et al. [33] demonstrated that intracellular
H2O2 accumulation inactivates MKPs by oxidation of their
catalytic cysteine, which leads to sustained activation of
JNK pathway. Hou et al. [34] further conﬁrmed that ROS-
induced MKP inactivation causes sustained activation of
JNK pathway. Choi et al. [35] showed that glutamate-
induced oxidative stress induces sustained activation of ERK
pathway through a mechanism that involves degradation of
MKP-1. It is worth pointing out that ROS can upregulate
MKP-1 expression. Zhou et al. [36] found that upregulation
of MKP-1 expression by H2O2 correlates with inactivation
of JNK and p38 activity. Kuwano and Gorospe [37] revealed
that the oxidant-triggered induction of MKP-1 is potently
inﬂuenced by two posttranscriptional processes, mRNA sta-
bilization and increased translation. Lornejad-Sch¨ afer et al.
[38] investigated the regulation of MKP-1 expression and
JNK activation by the induction of light damage that has
shown to enhance ROS production in ARPE-19 cells. In
their study, low light doses upregulated MKP-1 expression
in ARPE-19 cells, this being accompanied by inactivation of
JNK pathway. High light doses, however, led to a decrease
in the expression of MKP-1, resulting in sustained activation
of JNK pathway. Hence, the paradox in the roles of ROS
as “inducers” in the regulation of MKP-1 expression and as
“inhibitors” may be, at least in part, related to diﬀerences in
the concentrations of ROS.
6. Conclusion
T h ee v i d e n c es u p p o r t i n gt h a tR O Sc a na c t i v a t eM A P K
pathways at cellular levels is based largely on the following
ﬁndings: (1) cellular stimuli that are capable of producing
ROS can also activate MAPK pathways in a number of
diﬀerent cell types, (2) antioxidants and inhibitors of ROS-
producing enzymatic systems block MAPK activation, and
(3) exogenous addition of H2O2,o n eo fR O S ,a c t i v a t e s
MAPK pathways. The putative mechanisms by which ROS,
on the basis of their oxidation potentials, can activate
MAPK pathways may include (1) oxidative modiﬁcations of
MAPK signaling proteins (e.g., RTKs and MAP3Ks) and (2)
inactivation of MKPs, as illustrated in Figure 2. Finally, the
site of ROS production and the concentration and kinetics
of ROS production as well as cellular antioxidant pools
and redox state are most likely to be important factors
in determining the eﬀects of ROS on activation of MAPK
pathways.
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